Nordicus Partners Corporation (NORD)
Industrials · OQB
Price as at 1 Oct 2026, 02:39 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Nordicus Partners Corporation trades at $3.51, close to the $3.44 our fair value estimate puts on the business. On this measure the market and the model broadly agree, so the interesting question is which of them is wrong.
Our moat model scores it 10 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
NORD dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2020 | $90.00 | 1 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
About Nordicus Partners Corporation
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
NORD passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
NORD peers
The largest companies in the same industry (Consulting Services), then in the same sector.
- EFX Equifax Inc.
- ALQ.AX ALS Limited
- ICFI ICF International, Inc.
- CRAI CRA International, Inc.
- ROMA Roma Green Finance Limited
- LAWR Robot Consulting Co., Ltd.
- RGP Resources Connection, Inc.
- INTJ Intelligent Group Limited
Every industrials company we cover is on the Industrials hub.
Common questions
Is Nordicus Partners Corporation (NORD) undervalued?
Against our fair value estimate of $3.44, NORD at $3.51 is 2% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Where does SteadyShares get its NORD data?
Fundamentals for NORD come from company filings and exchange data, as listed on OQB; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 02:39 UTC and is delayed. Our data quality score for this company is 75/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for NORD, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.